LSD1 inhibition induces differentiation and cell death in Merkel cell carcinoma | EMBO Molecular Medicine
LSD1 inhibitors in clinical trials | Download Scientific Diagram
LSD1 activates a lethal prostate cancer gene network independently of its demethylase function | PNAS
LSD1: biologic roles and therapeutic targeting | Epigenomics
Annual review of lysine-specific demethylase 1 (LSD1/KDM1A) inhibitors in 2021 - ScienceDirect
Comprehensive in Vitro Characterization of the LSD1 Small Molecule Inhibitor Class in Oncology | ACS Pharmacology & Translational Science
Frontiers | Lysine-Specific Demethylase 1A as a Promising Target in Acute Myeloid Leukemia | Oncology
LSD1/KDM1A inhibitors in clinical trials: advances and prospects | Semantic Scholar
LSD1 as a Biomarker and the Outcome of Its Inhibitors in the Clinical Trial: The Therapy Opportunity in Tumor
Summary of LSD1/KDM1A inhibitors in clinical trials and clinical use. a | Download Table
Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy | Clinical Epigenetics | Full Text
New tranylcypromine derivatives containing sulfonamide motif as potent LSD1 inhibitors to target acute myeloid leukemia: Design, synthesis and biological evaluation - ScienceDirect
LSD1/KDM1A inhibitors in clinical trials: advances and prospects | Semantic Scholar
LSD1 inhibitors in clinical trials. | Download Table
LSD1/KDM1A inhibitors in clinical trials: advances and prospects | Journal of Hematology & Oncology | Full Text
Advances toward LSD1 inhibitors for cancer therapy | Future Medicinal Chemistry
LSD1 inhibitors in clinical trials | Download Scientific Diagram
Targeting the scaffolding role of LSD1 (KDM1A) poises acute myeloid leukemia cells for retinoic acid–induced differentiation
Pre-clinical activity of combined LSD1 and mTORC1 inhibition in MLL-translocated acute myeloid leukaemia | Leukemia
LSD1: biologic roles and therapeutic targeting | Epigenomics
Irreversible TCP-based LSD1 inhibitors 19-24. | Download Scientific Diagram
LSD1/KDM1A inhibitors in clinical trials: advances and prospects | Journal of Hematology & Oncology | Full Text
LSD1 inhibitors in clinical trials. (A) Structure of TCP-based... | Download Scientific Diagram
Frontiers | LSD1 Activates PI3K/AKT Signaling Through Regulating p85 Expression in Prostate Cancer Cells | Oncology
